Pretreatment with allopurinol in cardiac hypoxic-ischemic reperfusion injury in newborn lambs exerts its beneficial effect through afterload reduction

Basic Research in Cardiology

Volumn 94, Issue 1, 1999, Pages 23-30

  Shadid, M ^a   Van Bel, F ^a   Steendijk, P ^a   Dorrepaal, C A ^a   Moison, R ^a,b   Van Der Velde, E T ^a   Baan, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; ASCORBIC ACID; MALONALDEHYDE; OXYGEN RADICAL; THIOL DERIVATIVE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; BLOOD VOLUME; CONDUCTANCE; CONTROLLED STUDY; CORONARY SINUS; HEART AFTERLOAD; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; INTRAVENOUS DRUG ADMINISTRATION; LAMB; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; REPERFUSION INJURY; RESUSCITATION; VASCULAR RESISTANCE;

ALLOPURINOL; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; HEART RATE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; SHEEP;

EID: 0032932975     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050123     Document Type: Article

References (39)

1. Applegate RJ, Cheng CP, Little WC (1990) Simultaneous catheter and dimension assessment of left ventricular volume in the intact animal. Circulation 81: 638-648
2. Archie JP, Fixler DE, Ullyot DJ, Buckberg GD, Hoffman JIE (1974) Regional myocardial blood flow in lambs with concentric right ventricular hypertrophy. Circ Res 34: 143-154
3. Arnold WL, DeWall RA, Kezdi P, Zwart HHJ (1980) The effect of allopurinol on the degree of early myocardial ischemia. Am Heart J 99 (5): 614-624
4. Baan J, Van Der Velde ET (1988) Sensitivity of left ventricular end systolic pressure volume relation to type of loading intervention in dogs. Circ Res 62: 1247-1258
5. Baan J, Van Der Velde ET, De Bruin HG, Smeenk GJ, Koops J, Van Dijk AD, Temmerman D, Senden J, Buis B (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70 (5): 812-823
6. Becker BF, Reinholz N, Özcelik T, Leipert B, Gerlach E (1989) Uric acid as radical scavenger and antioxidant in the heart. Plügers Arch 415: 127-135
7. Becker BF (1993) Towards the physiological function of uric acid. Rad Biol Med 14: 615-631
8. Beckman JS (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15: 53-59
9. Behrman R, Lees M, Peterson E (1970) Distribution of the circulation in the normal and the asphyxiated primate. Am J Obstet Gynecol 108: 956-969
10. Bochenek A, Religa Z, Spyt TJ, Mistarz K, Bochenek AD, Zembela M, Grzybek H (1990) Protective influence of pretreatment with allopurinol on myocardial function in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 4: 538-542
11. Chambers DJ, Takahashi A, Humphrey SM, Harvey DM, Hearse DJ (1992) Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage. Basic Res Cardiol 87: 227-238
12. DeWall RA, Vasko KA, Stanley EL, Kezdi P (1971) Responses of the ischemic myocardium to allopurinol. Am Heart J 82 (3): 362-370
13. Dorrepaal CA, Van Bel F, Moison RMW, Shadid M, Van De Bor M, Steendijk P, Berger HM (1997) Oxidative stress during post hypoxic-ischemic reperfusion in the newborn lamb: The effect of nitric oxide synthesis inhibition. Pediatr Res 41: 321-326
14. Ferrari R (1994) Oxygen-free radicals at myocardial level: effects of ischemia and reperfusion. In: Armstrong, D (ed) Free Radicals in Diagnostic Medicine. Plenum Press: New York, pp 99-111.
15. Godin DV, Ko KM (1991) Allopurinol and ischemia/reperfusion injury: new use for an old drug? Can J Cardiol 7 (4): 163-169
16. Grossman W, Baim DS, ed. (1991) Cardiac Catheterisation and Angiography. Philadelphia, Lea, and Fabiger
17. Halliwell B , Chirico S (1993) Lipid peroxidation: its mechanism, measurements and significance. Am J Clin Nutr 57: 715S-725S
18. Halliwell B , Gutteridge JMC (1990) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280 (1): 1-8
19. Hellsten-Westing Y (1993) Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry 100: 215-222
20. Ko KM , Godin DV (1990) Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 40 (4): 803-809
21. Lew WYW (1988) Time dependent increase in left ventricular contractility following acute volume-loading in the dog. Circ Res 63: 635-647
22. Lindeman JHN, Van Zoeren-Grobben D, Schrijver J, Speek AJ, Poorthuis BJHM, Berger HM (1989) The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr Res 26: 20-24
23. Lopez-Anaya A, Mayersohn M (1987) Ascorbic and dehydroascorbic acids simultaneously quantified in biological fluids by liquid chromatography with fluorescence detection, and comparison with a colon-metric assay. Clin Chem 33: 1874-1878
24. Lux O, Naidoo D, Salonikas C (1992) Improved HPLC method tor the simultaneous measurement of allantoin and uric acid in plasma. Ann Clin Biochem 29: 674-675
25. Manfredi JP , Holmes EW (1985) Purine salvage pathways in myocardium. Ann Rev Physiol 47: 691-705
26. Maughan WL, Sunagawa K, Burkhoff D, Graves WL, Hunter WC, Sagawa K (1985) Effect of heart rate on the canine end-systolic pressure-volume relationship. Circulation 72 (3): 645-659
27. McCord JM (1985) Oxygen derived free radicals in post ischemic tissue injury. N Engl J Med 312: 159-163
28. Moorhouse PC, Grootveld M, Halliwell B, Quinlan JG, Gutteridge JMC (1987) Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS 213 (1): 23-28
29. Moriwaki Y, Yamamoto T, Suda M, Nasako Y, Takahashi N, Agbedana OE, Hada T, Higashino K (1993) Purification and immunohistochemical tissue localization of human xanthine oxidase. Biochim Biophys Acta 1164: 327-330
30. Saugstad OD (1996) Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 98: 103-107
31. Shadid M, Moison RMW, Hiltermann L, Berger HM, Van Bel F (1998) Anti oxidative combination therapy and post hypoxic-ischemic reperfusion injury of the newborn brain. Pediatr Res 44: 119-124
32. Suga H, Sagawa K, Shoukas AA (1973) Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32: 314-322
33. Teitel DF, Klautz RJM, Steendijk P, Van Der Velde ET, Van Bel F, Baan J (1991) The end-systolic pressure-volume relationship in the newborn lamb: effects of loading and inotropic interventions. Pediatr Res 29: 473-482
34. Van Der Velde ET, Burkhoff D, Steendijk P, Karsdon J, Sagawa K, Baan J (1991) Non-linearity and load sensitivity of the end-systolic pressure-volume relation of canine left ventricle in vivo. Circulation 83: 315-327
35. Van Jaarsveld H, Barnard HC, Maartens JJ, Potgieter GM (1989) Purine and oxypurine production in mitochondria of ischemic and reperfused myocardium. Enzyme 42: 136-144
36. Vettenranta K, Raivo KO (1990) Xanthine oxidase during human fetal development. Pediatr Res 27: 286-288
37. Walther FJ, Siassi B, Ramadan NA, Wu PYK (1985) Cardiac output in newborn infants with transient myocardial dysfunction. J Pediatr 107: 781-785
38. Werns SW, Grum CM, Ventura A, Hahn RA, Ho PPK, Towner RD, Fantone JC, Schork MA, Lucchesi BR (1991) Xanthine oxidase inhibition does not limit canine infarct size. Circulation 83: 995-1005
39. Werns SW, Shea MJ, Mitsos SE, Dysko RC, Fantone JC, Schork A, Abrams GD, Pitt B, Lucchesi BR (1986) Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation 73 (3): 518-524